material, and the timing of the filtration after blood collection were studied. Four filters were included in the study: three dry "online" filters and one wet "inline" filter. Filtrations were performed with these filters at different temperatures and time points to compare WBC removal under those conditions.
MATERIALS AND METHODS

Online filters
Blood collection and component preparation. Whole blood (mean, 470 mL; range, 405-495 mL) was collected from random donors in a triple top-and-bottom bag with 63 mL of CPD and in one satellite bag with 100 mL of saline-adenineglucose-mannitol (SAG-M) as additive for the RBCs (Compoflex, Fresenius Hemocare, Emmer-Compascuum, the Netherlands). All whole-blood donations were cooled to 20 to 24°C by using butane-1,4-diol plates.
14 By 16 to 20 hours after blood collection, the whole blood was centrifuged for 10 minutes at 2960 × g in a centrifuge ( J6MI, Beckman Instruments, Mijdrecht, the Netherlands) at RT (28,000 g/min). The whole blood was separated into plasma, buffy coat (BC), and RBC concentrate, by using an automated separator (Compomat G4, Fresenius Hemocare). 15 Pooling and dividing of the RBC concentrates. Donordependent differences were excluded by pooling and subsequently dividing 6 RBC concentrates with identical ABO/ Rh blood groups into the original bags. A 2-L pooling bag (BB*T2000BB, Terumo, Tokyo, Japan) was connected with the appropriate tubing, and the RBC concentrates were welded to the leads with a sterile connection device (SCD-201 A, Terumo). After the contents of the RBC bags were transferred to the pooling bag and mixed thoroughly, the contents of the pooling bag were divided equally into the original RBC bags. Next, the bags were disconnected by heat sealing, and the units were weighed.
Sampling of pooled, divided RBC concentrates. After pooling and dividing into each of the RBC bags, a 150-mL transfer bag (Compoflex P4159, Fresenius Hemocare) was welded. After thorough mixing, a 10-mL sample was obtained for in vitro analysis.
Filtration of the RBC concentrates. Filtrations were performed according to the instructions of the manufacturers. The following filters were used: Cellselect FR (Fresenius Hemocare), BioR-01-max (Fresenius Hemocare), and Leucoflex LCG1 (MacoPharma, Tourcoing, France). The Cellselect and the Leucoflex LCG1 filters have an air bypass, while the BioR-01-max has two breakers that allow sterile air to enter the filter housing. All filters were supplied by the manufacturers. First, an RBC concentrate was welded to each of the filters. RBC concentrates intended for filtration at 4°C were placed under a cooled (2-6°C) butane-1,4-diol plate and placed at 2 to 6°C. RBC concentrates were cooled to 4°C within 2 hours, as confirmed by temperature measurements (Escort, Auckland, New Zealand). Filtration of the cooled units was performed in a refrigerated room (2-6°C). The filters were filled by gravity, and the filtrations were performed by hanging the RBC concentrates approximately 1 m above the collection bag. Air was removed from the collection bag by expressing the air through the air bypass into the original RBC bag. For the BioR-01-max, the breakers were opened to allow sterile air to enter the filter. The air pushed the last blood from the filter housing. Filtrations were terminated when no blood was visible on the entrance side of the filter. For the BioR-01-max, the air in the collection bag was removed by expressing the air to the filter. After filtration, the weight of the filtered units was measured. A total of 12 experiments were performed.
Inline filter
Blood collection and component preparation. Whole blood (mean, 470 mL; range, 405-495 mL) was collected from random donors in a quadruple top-and-bottom collection system (FQT 6260P, MacoPharma). This system consisted of a primary collection bag containing 63 mL of CPD, connected to empty top and bottom bags. The bottom bag was connected to a fourth bag containing 100 mL of SAG-M. An inline filter (Leucoflex LCR4, MacoPharma) was present in the tubing between the bottom and the fourth bags. A breakaway cannula was present in the bottom bag, for the purpose of retaining the SAG-M in the fourth bag and in the filter, but not in the bottom bag. The bags were centrifuged and their contents separated into components the day after collection, as described above. After the separation procedure was completed, the breakaway cannula was opened and SAG-M added to the RBCs by hanging the SAG-M bag on a filtration rack. The filter was allowed to collapse for 5 minutes to minimize the amount of SAG-M in the filter. The tubing between the bottom bag and the filter was clamped to prevent blood flow to the filter.
The manufacturer stated that the online Leucoflex LCG1 filter and the inline LCR4 filter differed only by the type of sterilization and fiber wettability, as the Leucoflex LCR4 filter was used with SAG-M solution.
Pooling, dividing, and sampling the RBC concentrates. The pooling and dividing of RBC concentrates was performed as described above, with the exception that only three ABO-identical RBC concentrates were welded to a pooling bag. Samples for in vitro analysis were obtained as described above.
Filtration of the RBC concentrates. The study was divided into three arms: filtration immediately after blood component preparation at RT; filtration after a 2-hour hold under cold (2-6°C) butane-1,4-diol plates, as described above; and filtration after a 24-hour hold at 4°C. The temperature of the units was measured immediately before filtration. The contents of the bags were carefully mixed, and the temperature of the exterior of the bag was measured by an infrared thermometer (Bioblock Scientific, Illkirch, France). Filtrations of the cooled units were done in a refrigerated room at 2 to 6°C. The filtrations were performed by hanging the units approximately 1 m above the collection bags. The clamp was opened, and the filter was filled by gravity. Because the filter contained SAG-M before filtration, no air was present in the system, and, therefore, if the flexible filter housing had been completely emptied, removal of air from the collection bag was not necessary. The weight of the units was determined after filtration. Twelve filtration experiments were performed.
In vitro measurements
The volume of the RBCs was calculated by dividing the net weight of the content of the bag by the specific gravity of the units. Samples from the WBC-reduced RBCs were obtained by cutting the tubing, and the contents of the tubing were carefully mixed with the contents of the bag to obtain a representative sample. Hct values and WBC and platelet counts were determined with a cell analyzer (CA 570, Medonic, Bromma, Sweden). The volume of RBC concentrates was calculated from the Hct and the total volume of the unit. WBCs in the WBC-reduced RBC concentrates were counted in a Nageotte hemocytometer, using a 1-in-5 dilution in the lysing and counting solution (Leucoplate, Labo International, Maarssen, the Netherlands); the volume of the whole chamber (50 µL) was counted. If no cells were observed, the RBC concentrate was said to contain <0.03 × 10 6 WBCs per unit of 300 mL. Absolute numbers of WBCs and platelets per unit were calculated from the volume and the cell counts.
Specifications for WBC-reduced RBC concentrates
According to current Dutch national specifications, 16 a unit of WBC-reduced RBC concentrates should have the following composition: volume, >220 mL; Hb, >36 g; WBCs, <5 × 10 6 (preferably <1 × 10 6 ); and platelets, <15 × 10 9 per unit.
Statistical analysis
The paired t test was used to compare differences within the pooled experiments: that is, the influence of the temperature, the filter used, and the holding time of the RBC units. The unpaired t test was used for all other comparisons. A p value <0.05 was considered to indicate a significant difference.
RESULTS
Composition of pooled, divided RBC concentrates
The composition of the pooled and subsequently divided RBC concentrates is shown in Table 1 . For none of the various sets of pools were significant differences in the measured values observed, and therefore the results are represented as a mean of all 72 samples for the online filters and of all 36 samples for the inline filter.
Because of the retention of SAG-M in the filter, the total volume of the RBC concentrates was lower in the inline filter than in the online filters (p<0.0001); this resulted in a higher Hct (p<0.0001). In both collection procedures, almost equal RBC volumes were found. Another difference was the number of WBCs in the RBC concentrates of the two sets of experiments (p<0.0001). A possible explanation might be the sticking of BC cells to the Fresenius bag wall after the hard-spin centrifugation of the whole blood, and this was observed visually. If the BC layer was pushed upward during the component separation on the Compomat, some of the sticking BC cells remained in the lower compartment and were eventually expressed to the RBC concentrate. The MacoPharma bag walls did not induce this effect (visual observation).
WBC removal
Online filters. As shown in Table 2 , the Cellselect FR filter showed a temperature-dependent WBC removal, with residual WBC levels twice as high after filtration at RT as at 4°C. The other two filters had almost identical WBC removal at both temperatures.
Inline filter. The Leucoflex LCR4 filter showed a significantly better WBC removal at 4°C than at RT (p<0.0001; Table 3 ). A highly significant difference in WBC removal (p<0.0001) was also observed when we compared a storage and cooling period of 2 hours at 4°C to one of 24 hours at 4°C. The temperature at filtration varied less than 1°C (see Table 3 ).
Platelet removal and RBC loss
Platelet removal was on average 23 ± 21 percent for the tested filters, but it should be noted that, before filtration, the numbers were already well below the specifications for WBC-reduced RBC concentrates. For the Cellselect FR and the BioR-01-max filters, the RBC loss was roughly the same, on average 23 ± 2 mL (n = 24). The Leucoflex LCG1 has a large housing, which resulted in a greater RBC loss of 31 ± 4 mL (n = 24). With the Leucoflex LCR4 filter, the RBC loss was on average 25 ± 7 mL (n = 36). 
DISCUSSION
Various measures determining the WBC-removing capacity from RBC concentrates have been investigated by using commercially available filters. In this study, we evaluated the influence of the filtration temperature, the wettability of the filter material, and the timing of filtration. For two of the four investigated filters, the Cellselect FR and the Leucoflex LCR4, a significant influence of the filtration temperature was found. For the other two tested filters, the temperature did not influence the WBC removal. The influence of temperature has been found before, 7-11 but others have also shown that this effect is not necessarily present in all polyester filters. 17 For the Leucoflex LCR4 filter, not only the temperature but also the storage time influenced the performance. A significantly better WBC removal was seen when the RBC units had been cooled to 4°C and stored for 24 hours after component preparation than when there was a 2-hour cooling period. The temperature of the RBC concentrates varied on average less than 1°C. We do not have a clear explanation for the time-dependent WBC removal. It could be that neutrophils partly or fully disintegrate, 18 inducing microaggregate formation, and that these microaggregates are more easily captured in the filter. WBC fragments are not removed by filtration 19 and could be present in the filtrate. One study showed that, with the Leucoflex LCR4 filter, no WBC fragments could be detected in the RBC concentrate after filtration. 20 Our results with the Leucoflex LCR4 are in agreement with those of Müller, 21 who found residual WBC values on the order of 0.03 × 10 6 per unit of RBC concentrate with filtration after 16, 24, and 30 hours at 4°C. This study suggests that, if the RBC concentrates have been cooled for 16 hours, extension of the cooling period does not influence the filtration efficacy.
Bontadini et al. 22 investigated the BioR-01-max filter and performed filtration after a 24-hour cooling period at 4°C. With a prefiltration load of the filter with on average 900 × 10 6 WBCs, they found a postfiltration WBC count of less than 0.004 × 10 6 per unit. In contrast, after a 2-hour cooling period that was used in our present study, a much higher average of 0.62 × 10 6 WBCs per unit was found. We think these results could also suggest time-dependent WBC removal. Additional studies are needed to establish the mechanism causing this effect.
Comparison of the dry Leucoflex LCG1 with the wet Leucoflex LCR4 showed significant differences in residual WBCs. The manufacturer reported that the only difference between these filters is the wettability of the polyester fibers. The enhanced wettability of the fibers in the Leucoflex LCR4 filter apparently resulted in changing the removal of WBCs, which also became temperature dependent.
Finally, to prevent donor-dependent differences and to allow a limited number of units to be tested, RBC concentrates were pooled before filtration. We cannot exclude the possibility that the pooling procedure elicits a reaction, much like an MLC that might influence the WBC-removing capacity of the filters, although this has never been described. Because such a reaction is hypothetical, we feel that the method's advantages outweigh the disadvantages.
In conclusion, this study shows that many variables influence the removal of WBCs from RBC concentrates. For the routine filtration procedures at the blood center, this means that all variables should be identified, validated, and monitored. In addition, manufacturers should report all modifications made to a filter, in which case the blood center must perform additional validations.
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